SEI Investments’s iRadimed IRMD Stock Holding History

SEI Investments’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.15M	Buy	74,304 +10,908	+17%	+$1.09M	0.01%	1313
2025 Q4	$6.17M	Buy	63,396 +39,368	+164%	+$3.38M	0.01%	1290
2025 Q3	$1.71M	Buy	24,028 +1,556	+7%	+$104K	﹤0.01%	1766
2025 Q2	$1.35M	Buy	22,472 +4,848	+28%	+$266K	﹤0.01%	1803
2025 Q1	$924K	Buy	17,624 +4,874	+38%	+$274K	﹤0.01%	1935
2024 Q4	$703K	Buy	12,750 +686	+6%	+$36.1K	﹤0.01%	2072
2024 Q3	$606K	Buy	12,064 +1,617	+15%	+$74.6K	﹤0.01%	2116
2024 Q2	$459K	Buy	10,447 +3,896	+59%	+$166K	﹤0.01%	2193
2024 Q1	$288K	Buy	6,551 +2,307	+54%	+$102K	﹤0.01%	2319
2023 Q4	$201K	Buy	+4,244	New	+$178K	﹤0.01%	2435
2023 Q3	–	Sell	-4,244	Closed	-$203K	–	2652
2023 Q2	$203K	Buy	+4,244	New	+$191K	﹤0.01%	2476

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments's IRMD Position: Q1 2026 in Review

SEI Investments increased its iRadimed (IRMD) stake by 17% in Q1 2026, buying an estimated $1.09M and bringing the position to 74,304 shares worth $7.15M. The position accounts for 0.01% of the portfolio, ranked #1313.

SEI Investments first reported a position in IRMD in Q2 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

SEI Investments held 74,304 shares of iRadimed worth $7.15M as of Q1 2026.
SEI Investments bought 10,908 iRadimed shares in Q1 2026, an estimated $1.09M.
iRadimed made up 0.01% of SEI Investments's portfolio in Q1 2026, its #1313 holding.
SEI Investments first reported a position in iRadimed in Q2 2023 and has held it in 11 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.